Schlenk, Richard F. 2024. “Genetics As Predictive Marker for Consolidation Therapy With High-Dose Cytarabine in Acute Myeloid Leukemia”. Haematologica 109 (6). Pavia, Italy, 1629-30. https://doi.org/10.3324/haematol.2024.285624.